Product Information
NYSTATIN-TRIAMCINOLONE OINTMENT is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.2354 per GM under NDC 33342048360. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Aug 17, 2021. Its Orange Book therapeutic-equivalence code is AT.
Strength
100000; 1 [USP'U]/g; mg/g
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342048360
Classification
Generic
Dosage Form
OINTMENT
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
NYSTATIN; TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214751FDA Approved
8/17/2021
TE Code
AT
On Market Since
9/1/2021
Pharmacological Classes
Price Statistics
The NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has been published 226 times since Jun 8, 2022, and over the history we have for it it has declined 39.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2354 per GM |
|---|---|
| All-time high | $0.3881 (Jun 15, 2022) |
| All-time low | $0.1662 (Jan 18, 2023) |
| 52-week high | $0.2479 |
| 52-week low | $0.2058 |
| Median price | $0.2321 |
| Average price | $0.2359 |
| Largest weekly change | +73.9% (Mar 20, 2024) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Nystatin and triamcinolone acetonide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nystatin and triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NYSTATIN-TRIAMCINOLONE OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for NYSTATIN-TRIAMCINOLONE OINTMENT, manufactured by Macleods Pharmaceuticals Limited, is $0.2354 per GM (NDC 33342048360), effective Sep 30, 2026.
How has the price of NYSTATIN-TRIAMCINOLONE OINTMENT changed over time?
Over the history we have for it, the NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has declined 39.4%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for NYSTATIN-TRIAMCINOLONE OINTMENT?
Since Jun 8, 2022, the NADAC for NYSTATIN-TRIAMCINOLONE OINTMENT has ranged from a low of $0.1662 (Jan 18, 2023) to a high of $0.3881 (Jun 15, 2022), with a median of $0.2321 per GM.
Are there cheaper alternatives to NYSTATIN-TRIAMCINOLONE OINTMENT?
No other NADAC-published product currently shares the active ingredient and strength of NYSTATIN-TRIAMCINOLONE OINTMENT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures NYSTATIN-TRIAMCINOLONE OINTMENT?
NYSTATIN-TRIAMCINOLONE OINTMENT (NDC 33342048360) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.